MUC1-Poly-ICLC

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMUC1-Poly-ICLC
Drug Alias NameMUC1-poly-ICLC
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionMucin-1 modulators
TargetsMucin-1
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungColorectal NeoplasmsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pittsburgh
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of PittsburghUniversity Of Virginia
Inactive CompaniesNational Cancer Institute
Active IndicationsCarcinoma, Non-Small-Cell LungMelanoma
Inactive IndicationsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A